Retroviruses and retroelements in diseases and in gene therapy
Svoboda, J.
Folia Biologica 42(6): 283-294
1996
ISSN/ISBN: 0015-5500 PMID: 9158938 Document Number: 457096
Document emailed within 1 workday
Related Documents
Drescher, B.; Möhring, R.; Winkler, J.; Nyakatura, G.; Rosenthal, S. 1985: Partial sequence homology between retroviruses of various species in the C-terminal part of the env gene Folia Biologica 31(2): 93-106Coutant, R.; MacLaren, N.K. 1999: Retroviruses and autoimmune endocrine diseases Annales de Medecine Interne 150(3): 235-244
Attramadal, H.; Berg, K. 2001: Gene therapy in cardiovascular diseases Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 121(4): 489-491
Viet Tran, H.; Schorderet, D.F.; Kostic, C.; Munier, F.L.; Arsenijevic, Y. 2009: Gene therapy for hereditary eye diseases: where are we? Revue Medicale Suisse 5(186): 118-123
Sangro, B.; Ruiz, J.; Qian, C.; Prieto, J. 2000: Gene therapy for liver diseases Gastroenterologia y Hepatologia 23(8): 394-402
Mornex, J.F. 1998: What can be expected from gene therapy in respiratory diseases? Presse Medicale 27(16): 769-770
Ohashi, T. 2010: Gene therapy for lysosomal storage diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 8): 665-669
Mazzolini, G.; Ruiz, J.; Qian, C.; Prieto, J. 2001: Gene therapy: its contributions to liver and kidney diseases Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 21(Suppl 1): 17-23
Fan, L.; Jiang, X.-g. 2010: Development of gene therapy in major brain diseases Yao Xue Xue Bao 45(9): 1095-1102
Lakatos, P.L.; Lakatos, L.; Pár, A.; Papp, J. 2001: Molecular genetics and gene therapy in diseases of the esophagus, stomach, colon and pancreas Orvosi Hetilap 142(52): 2883-2891
Tong, X.W.; Engehausen, D.G.; Kaufman, R.H.; Agoulnik, I.; Contant, C.; Freund, C.T.; Oehler, M.K.; Kim, T.E.; Hasenburg, A.; Woo, S.L.; Kieback, D.G. 1998: Improvement of gene therapy for ovarian cancer by using acyclovir instead of ganciclovir in adenovirus mediated thymidine kinase gene therapy Anticancer Research 18(2a): 713-718
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Fehmann, H.C.; Göke, B. 1994: One gene--four diseases: on the importance of mutations in the ret gene in MEN 2A, MEN 2B, Hirschsprung disease and medullary thyroid carcinoma Zeitschrift für Gastroenterologie 32(7): 416-417
Guo, M.-g.; Jiang, M.-h.; Yang, Q.; Li, Y.-m.; Cui, Z.-f.; Li, L.-f.; Wu, M.-c.; Qian, Q.-j. 2004: Gene therapy for ovarian cancers by adenovirus-mediated complete antibody gene Zhonghua Yi Xue Za Zhi 84(14): 1147-1151
Yoon, S.J.; Heo, D.S.; Kang, J.O.; Kim, N.K. 1999: Combination gene therapy of IL-12 and allogeneic MHC class i gene via stimulating NK cytolytic activity Anticancer Research 19(5b): 4337-4342
Grgić, M. 2000: Gene therapy of tumors of the head and neck: clinical use of the p53 tumor suppressor gene Lijecnicki Vjesnik 122(1-2): 14-16
Bubeník, J.; Zeuthen, J.; Bubeníková, D.; Símová, J.; Jandlová, T. 1993: Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets Anticancer Research 13(5a): 1457-1460
Bellon, G. 1998: From gene transfer to gene therapy in cystic fibrosis, how long is the road? La Revue du Praticien 48(1): 5-8
Cooper, M.J. 1996: Noninfectious gene transfer and expression systems for cancer gene therapy Seminars in Oncology 23(1): 172-187
Kaneda, Y.; Morishita, R. 1997: Development of in vivo gene transfer methods towards future gene therapy Rinsho Byori. Japanese Journal of Clinical Pathology 45(2): 99-105